AvroBio Inc. (AVRO) NASDAQ
$1.19 (0.02) (-1.65%)
Market Cap: $54.28M
As of 04/29/24 04:30 PM EDT. Market closed.
AvroBio Inc. (AVRO)
NASDAQ
$1.19
(0.02) (-1.65%)
Market Cap: $54.28M
As of 04/29/24 04:30 PM EDT. Market closed.
Add to Portfolio
clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO Compensation (Base)
$462,267
CEO Compensation (Total)
$2.87M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
95
CEO Compensation (Base)
$462,267
CEO Compensation (Total)
$2.87M
URL
Address
.
PRICE CHART FOR AVROBIO INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.20
Previous Close
$1.21
Days Range
$1.18 - $1.21
52 week range
$0.57 - $1.70
Volume
142,738
Avg. Volume (30 days)
125,020
Market Cap
$54.28M
Dividend Yield
-
P/E
-
Shares Outstanding
44,860,515
Open
$1.20
Previous Close
$1.21
Days Range
$1.18 - $1.21
52 week range
$0.57 - $1.70
Volume
142,738
Avg. Volume (30 days)
125,020
Market Cap
$54.28M
Dividend Yield
-
P/E
-
Shares Outstanding
44,860,515
FINANCIAL STATEMENTS FOR AVROBIO INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR AVROBIO INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Golipour Azadeh | Chief Technology Officer | Feb 05, 2024 | Option Exercise | $1.20 | 12,232 | 14,698 | 55,872 | Feb 05, 2024, 08:01 PM |
| Ridha Essra | Chief Medical Officer | Feb 05, 2024 | Option Exercise | $1.20 | 16,953 | 20,354 | 15,881 | Feb 05, 2024, 07:59 PM |
| Ostrowski Erik | Interim CEO, President and CFO | Feb 05, 2024 | Option Exercise | $1.20 | 13,099 | 15,745 | 29,285 | Feb 05, 2024, 07:57 PM |
| Avruch Steven | Chief Legal Officer | Feb 05, 2024 | Option Exercise | $1.20 | 10,812 | 12,996 | 22,022 | Feb 05, 2024, 07:56 PM |
| Golipour Azadeh | Chief Technology Officer | Jun 12, 2023 | Option Exercise | $1.19 | 5,574 | 6,635 | 30,881 | Jun 13, 2023, 04:32 PM |
| MACKAY GEOFFREY | President & CEO | Jan 24, 2023 | Option Exercise | $0.91 | 45,999 | 41,859 | 188,012 | Jan 26, 2023, 05:30 PM |
| MACKAY GEOFFREY | President & CEO | Dec 23, 2022 | Option Exercise | $0.41 | 142,013 | 58,680 | 387,136 | Dec 28, 2022, 07:18 PM |
| Vickers Philip J. | Director | Jul 07, 2021 | Buy | $8.35 | 4,800 | 40,080 | 4,800 | Jul 08, 2021, 04:21 PM |
| Donenberg Phillip B. | Director | Feb 17, 2021 | Buy | $11.71 | 2,000 | 23,420 | 2,000 | Feb 18, 2021, 07:06 PM |
| MACKAY GEOFFREY | President & CEO | Dec 24, 2020 | Option Exercise | $0.41 | 100,000 | 41,320 | 245,123 | Dec 28, 2020, 07:46 PM |
| MACKAY GEOFFREY | See Remarks | Feb 12, 2020 | Sale | $29.07 | 1,400 | 40,692 | 345,123 | Feb 14, 2020, 07:16 PM |
| PAIGE CHRISTOPHER | Director | Feb 11, 2020 | Sale | $28.00 | 15,000 | 420,000 | 252,512 | Feb 11, 2020, 09:26 PM |
| MACKAY GEOFFREY | See Remarks | Feb 11, 2020 | Sale | $27.57 | 63,000 | 1,737,081 | 364,927 | Feb 11, 2020, 09:23 PM |
| PAIGE CHRISTOPHER | Director | Jan 28, 2020 | Sale | $23.00 | 10,000 | 230,000 | 267,512 | Jan 30, 2020, 04:10 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Jul 19, 2019 | Buy | $18.50 | 810,811 | 15,000,004 | 5,567,289 | Jul 23, 2019, 04:09 PM |
| Booth Bruce | Director | Jul 19, 2019 | Buy | $18.50 | 810,811 | 15,000,004 | 5,567,289 | Jul 23, 2019, 04:09 PM |
| PAIGE CHRISTOPHER | Director | Apr 08, 2019 | Sale | $25.89 | 2,500 | 64,713 | 277,612 | Apr 09, 2019, 04:39 PM |
| PAIGE CHRISTOPHER | Director | Apr 05, 2019 | Sale | $25.66 | 7,500 | 192,483 | 280,879 | Apr 09, 2019, 04:39 PM |
| MACKAY GEOFFREY | See Remarks | Apr 08, 2019 | Sale | $27.07 | 698 | 18,893 | 409,523 | Apr 09, 2019, 04:27 PM |
| MACKAY GEOFFREY | See Remarks | Apr 05, 2019 | Sale | $27.26 | 13,302 | 362,618 | 410,221 | Apr 09, 2019, 04:27 PM |
| Dorton Katina | Chief Financial Officer | Oct 08, 2018 | Option Exercise | $0.91 | 10,000 | 9,100 | 10,000 | Oct 10, 2018, 06:11 PM |
| KREHER NERISSA | Chief Medical Officer | Oct 08, 2018 | Option Exercise | $0.91 | 2,942 | 2,677 | 2,942 | Oct 10, 2018, 06:05 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Golipour Azadeh | Chief Technology Officer | 02/05/2024 | 14,698 |
| Ridha Essra | Chief Medical Officer | 02/05/2024 | 20,354 |
| Ostrowski Erik | Interim CEO, President and CFO | 02/05/2024 | 15,745 |
| Avruch Steven | Chief Legal Officer | 02/05/2024 | 12,996 |
| Golipour Azadeh | Chief Technology Officer | 06/12/2023 | 6,635 |
| MACKAY GEOFFREY | President & CEO | 01/24/2023 | 41,859 |
| MACKAY GEOFFREY | President & CEO | 12/23/2022 | 58,680 |
| Vickers Philip J. | Director | 07/07/2021 | 40,080 |
| Donenberg Phillip B. | Director | 02/17/2021 | 23,420 |
| MACKAY GEOFFREY | President & CEO | 12/24/2020 | 41,320 |
| MACKAY GEOFFREY | See Remarks | 02/12/2020 | 40,692 |
| PAIGE CHRISTOPHER | Director | 02/11/2020 | 420,000 |
| MACKAY GEOFFREY | See Remarks | 02/11/2020 | 1,737,081 |
| PAIGE CHRISTOPHER | Director | 01/28/2020 | 230,000 |
| Atlas Venture Fund X, L.P. | 10% Owner | 07/19/2019 | 15,000,004 |
| Booth Bruce | Director | 07/19/2019 | 15,000,004 |
| PAIGE CHRISTOPHER | Director | 04/08/2019 | 64,713 |
| PAIGE CHRISTOPHER | Director | 04/05/2019 | 192,483 |
| MACKAY GEOFFREY | See Remarks | 04/08/2019 | 18,893 |
| MACKAY GEOFFREY | See Remarks | 04/05/2019 | 362,618 |
| Dorton Katina | Chief Financial Officer | 10/08/2018 | 9,100 |
| KREHER NERISSA | Chief Medical Officer | 10/08/2018 | 2,677 |
Load More Insider Transactions
FUNDS WITH A POSITION IN AVROBIO INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 758,943 | 0.0016% | 46.38% | Other |
| BLACKROCK INC. | 614,708 | 0.00002% | -1.26% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 366,516 | 0.00005% | 3.79% | Other |
| GABELLI FUNDS LLC | 343,421 | 0.0036% | New | Event Driven, Growth, Activists |
CHANGE IN SHARES OUTSTANDING FOR AVROBIO INC
STOCK BUYBACKS FOR AVROBIO INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
1.05%
1Q
06/30/2023
1.61%
2Q
03/31/2023
2.17%
3Q
12/31/2022
2.75%
4Q
09/30/2022
2.79%
5Q
06/30/2022
2.97%
6Q
03/31/2022
2.97%
7Q
12/31/2021
3.07%
8Q
09/30/2021
3.14%
9Q
06/30/2021
5.84%
10Q
03/31/2021
8.11%
11Q
12/31/2020
16.57%
12Q
09/30/2020
23.46%
13Q
06/30/2020
24.62%
14Q
03/31/2020
33.64%
15Q
12/31/2019
42.07%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AVROBIO INC
LOADING...